Risk Communication Regarding Drug Safety

Quantification and Communication of Construction Safety Risk

Construction risk is typically defined in terms of likelihood and severity and is quantified by multiplying the probability of an event by the potential impact of that event on project budget or schedule. The quantification and communication of construction safety risk, however, involves the application of safety terminology and management techniques to the field of risk management. This paper ...

Safety vs. reputation: risk controversies in emerging policy networks regarding school safety in the Netherlands

Early drug development: assessment of proarrhythmic risk and cardiovascular safety.

INTRODUCTION hERG assays and thorough ECG trials have been mandated since 2005 to evaluate the QT interval and potential proarrhythmic risk of new chemical entities. The high cost of these studies and the shortcomings inherent in these binary and limited approaches to drug evaluation have prompted regulators to search for more cost effective and mechanistic paradigms to assess drug liability as...

Cardiac safety, risk management, and oncology drug development.

Cardiac safety biomarkers are increasingly employed in the preclinical and clinical development of investigational oncology products. Irrespective of overt clinical toxicities, cardiacrelated laboratory tests can influence decision making at many levels during the conduct of clinical studies, including eligibility for protocol therapy, dose delivery or discontinuation, and analyses of optimal d...

Patient-provider communication regarding drug costsin Medicare Part D beneficiaries with diabetes: a TRIAD Study

BACKGROUND Little is known about drug cost communications of Medicare Part D beneficiaries with chronic conditions such as diabetes. The purpose of this study is to assess Medicare Part D beneficiaries with diabetes' levels of communication with physicians regarding prescription drug costs; the perceived importance of these communications; levels of prescription drug switching due to cost; and ...